FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Askina SilNet dressing 7.5cm x 10cm (B.Braun Medical Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Soft silicone wound contact dressing sterile 7.5cm x 10cm 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Soft silicone wound contact dressing sterile 7.5cm x 10cm 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Askina SilNet dressing 10cm x 18cm (B.Braun Medical Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Soft silicone wound contact dressing sterile 5cm x 7.5cm 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Soft silicone wound contact dressing sterile 5cm x 7.5cm 3 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mepitel dressing 7.5cm x 10cm (Molnlycke Health Care Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Soft silicone wound contact dressing sterile 5cm x 7.5cm 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mepitel dressing 5cm x 7.5cm (Molnlycke Health Care Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Soft silicone wound contact dressing sterile 10cm x 18cm 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Askina SilNet dressing 5cm x 7.5cm (B.Braun Medical Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mepitel dressing 10cm x 18cm (Molnlycke Health Care Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Soft silicone wound contact dressing sterile 10cm x 18cm 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mepitel dressing 5cm x 7.5cm (Molnlycke Health Care Ltd) 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Askina SilNet dressing 10cm x 18cm (B.Braun Medical Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mepitel dressing 5cm x 7.5cm (Molnlycke Health Care Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Askina SilNet dressing 5cm x 7.5cm (B.Braun Medical Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mepitel dressing 10cm x 18cm (Molnlycke Health Care Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mepitel dressing 7.5cm x 10cm (Molnlycke Health Care Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Askina SilNet dressing 5cm x 7.5cm (B.Braun Medical Ltd) 3 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Askina SilNet dressing 10cm x 18cm (B.Braun Medical Ltd) 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Askina SilNet dressing 7.5cm x 10cm (B.Braun Medical Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mepitel dressing 7.5cm x 10cm (Molnlycke Health Care Ltd) 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mepitel dressing 10cm x 18cm (Molnlycke Health Care Ltd) 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Askina SilNet dressing 7.5cm x 10cm (B.Braun Medical Ltd) 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely thioridazine hydrochloride 10 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely thioridazine hydrochloride 25 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely thioridazine hydrochloride 50 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rideril 50mg tablets (Dr Reddy's Labs) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 50mg tablets 84 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets 500 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 50mg tablets 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 10mg tablets 84 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Melleril 50mg tablets (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 50mg tablets (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 50mg tablets (Kent Pharma (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rideril 25mg tablets (Dr Reddy's Labs) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets 84 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (Kent Pharma (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 10mg tablets 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 50mg tablets 500 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Melleril 25mg tablets (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Melleril 10mg tablets (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 10mg tablets (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 50mg tablets 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 50mg tablets (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 50mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 50mg tablets 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (A A H Pharmaceuticals Ltd) 84 tablet 6 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 50mg tablets (Unichem Plc) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rideril 50mg tablets (Dr Reddy's Labs) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (Kent Pharma (UK) Ltd) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rideril 25mg tablets (Dr Reddy's Labs) 500 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Melleril 25mg tablets (Novartis Pharmaceuticals UK Ltd) 84 tablet 6 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 50mg tablets (Special Order) 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (Kent Pharma (UK) Ltd) 500 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (Unichem Plc) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 50mg tablets (A A H Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (A A H Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 50mg tablets (Kent Pharma (UK) Ltd) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 10mg tablets (Special Order) 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rideril 25mg tablets (Dr Reddy's Labs) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (Unichem Plc) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 50mg tablets (A A H Pharmaceuticals Ltd) 84 tablet 6 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Melleril 50mg tablets (Novartis Pharmaceuticals UK Ltd) 84 tablet 6 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thioridazine 25mg tablets (Special Order) 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Melleril 10mg tablets (Novartis Pharmaceuticals UK Ltd) 84 tablet 6 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rideril 50mg tablets (Dr Reddy's Labs) 500 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
CalCough Children's Soothing syrup (McNeil Products Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benylin Children's Blackcurrant Flavour Cough syrup (McNeil Products Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
CalCough Children's Soothing syrup (McNeil Products Ltd) 125 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benylin Children's Blackcurrant Flavour Cough syrup (McNeil Products Ltd) 125 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 100 transdermal patches (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 25 transdermal patches (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 50 transdermal patches (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 75 transdermal patches (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Idrolax 10g oral powder sachets (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Doncaster Pharmaceuticals Ltd) 21 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 100 transdermal patches (Doncaster Pharmaceuticals Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 25 transdermal patches (Doncaster Pharmaceuticals Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 50 transdermal patches (Doncaster Pharmaceuticals Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 75 transdermal patches (Doncaster Pharmaceuticals Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Idrolax 10g oral powder sachets (Doncaster Pharmaceuticals Ltd) 20 sachet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic Fresubin 1500 Complete liquid VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fresubin 1500 Complete liquid (Fresenius Kabi Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Fresubin 1500 Complete liquid 1.5 litre VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fresubin 1500 Complete liquid (Fresenius Kabi Ltd) 1.5 litre VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Beclometasone 0.025% cream (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Beclometasone 0.025% ointment (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Beclometasone 0.025% cream (Alliance Healthcare (Distribution) Ltd) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Beclometasone 0.025% ointment (Alliance Healthcare (Distribution) Ltd) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Microdot lancets 0.31mm/30gauge (Cambridge Sensors Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Essential Generics Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g ointment (Essential Generics Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 44 of 86 Next End

This concept is not in any reference sets

Back to Start